Why the study?
What are the outcomes of orthotopic heart transplantation in a Norwegian cohort?
What are the outcomes of orthotopic heart transplantation in a Norwegian cohort?
Answers are grounded in this paper and cite their sources.
Early experience with orthotopic heart transplantation in Norway demonstrated feasibility with 5 of 8 patients surviving in good condition despite 3 early deaths.
Eight patients underwent orthotopic heart transplantation in Norway during 1984, with retransplantation in one case. The age range of the 5 men and 3 women was 19-53 years. The preoperative diagnosis was cardiomyopathy in 6 patients, ischaemic heart disease in one, and a combination of the two disorders in one patient. The immunosuppressive regimen, with cyclosporin A and low-dose prednisolone, and the treatment of graft rejection, followed the Stanford University protocol. There was no operative mortality. Three patients died shortly after the transplantation, 2 of them after about a week from acute rejection; in one of these 2 cases a second transplant was made, but was followed by pulmonary and renal complications. The third death occurred about 10 weeks postoperatively, from donor heart failure due to Toxoplasma myocarditis. The 5 survivors are clinically in good condition.
No takes yet. Share an insight, caveat, or question.
Fröysaker et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: